Emergency (24/7) Plumbing

patients showed that oral doses of CBD ranging from 150-400 mg/day, combined with classic antiparkinsonian agents, reduced psychotic symptoms evaluated by different scales (the Brief...

Studies show that CBD can increase AEA concentration by blocking the AEA membrane transporter (AMT) or the FAAH enzyme, which...

Despite the consensus among researchers on the potential of CBD as a neuroprotective agent, larger and well-designed randomized clinical trials will be...

One of them is a family of ionotropic receptors permeable to monovalent cations and calcium named transient receptor potential vanilloid (TRPV).

An open-label pilot study conducted in PD patients showed that oral doses of CBD ranging from 150-400 mg/day, combined with classic antiparkinsonian agents, reduced psychotic...

Therefore, double-blind, placebo-controlled, randomized trials with larger samples of patients with PD are needed to elucidate the possible effectiveness and mechanisms...

CBD also protected SH-SY5Y cells against LPS- and β-amyloid-induced decreases in cell viability, while increasing the viability of SH-SY5Y cells incubated with conditioned media derived...

An open-label pilot study conducted in PD patients showed that oral doses of CBD ranging from 150-400 mg/day, combined with classic antiparkinsonian agents, reduced psychotic...

Studies show that CBD can increase AEA concentration by blocking the AEA membrane transporter (AMT) or the...

Besides, several studies have described CBD as a multitarget molecule, acting as an adaptogen and as a modulator, in different ways, depending...